Fig. 2From: Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancerThe association of NNMT expression with clinical and molecular parameters. a, b and c Increased expression of NNMT was associated with increased tumor stage (a), grade (b) and mesenchymal molecular subtype (c). d Differential expression of NNMT between drug-resistant and drug-sensitive ovarian cancersBack to article page